Loading clinical trials...
Loading clinical trials...
The investigational drug, SOB100, is an HLA-G targeted exosome equipped with a nanobody namely anti-HLA-G VHH on the exosome membrane. This is a Phase I dose escalation study to exam the tolerability,...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Shine-On Biomedical Co., Ltd.
NCT07040956 · Head and Neck Squamous Cell Carcinoma, Low-dose Radiotherapy, and more
NCT07032727 · Targeted Therapy, IDH1-Mutated Malignancies, and more
NCT06856993 · Sudden Cardiac Death, Exosome Multiomics, and more
NCT06342713 · Healthy Participants, Healthy Subjects, and more
NCT06014515 · Healthy Subjects, Cardiovascular Disease
Parexel International - Baltimore Early Phase Clinical Unit
Baltimore, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions